SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Generate Capital ("Generate"), a leading investor, owner and operator of critical infrastructure, today announced the closing of a $117 million term debt ...

A group of Stanford students drove across eight states this summer, on a trip fueled not by gas or electricity but sunlight. They did so as part of the 2026 American Solar Challenge, a biennial ...

Matthew Rodriguez is a digital producer for CBS Los Angeles. He's previously reported for local outlets like the Argonaut and Pasadena Weekly. Matt typically covers breaking news and crime. Julie ...

As more and more data centers are proposed throughout the region and the state, the issues critics bring to the table are becoming fairly familiar — the amount of water used to cool the servers, air ...

Has Elon Musk given up on Tesla’s Master Plans, on the electrified economy, on solar power as we know it? From the SpaceX IPO filing released this week, it sure seems like it. A recap for those not ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

Pragmata's map is bigger and more full of secrets than you might expect from what initially seems like a series of hallways. Nooks filled with danger and crannies hiding treasure abound, but it's easy ...

With over five years in the web and tech space, I’ve developed a deep passion for PC hardware and peripherals. I’m a habitual researcher, always eager to learn more, which has expanded my knowledge ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...